Guideline treatment results in regression of atherosclerosis in type 2 diabetes mellitus

Conclusions:
Guideline treatment arrests atherogenesis in non-diabetes mellitus patients and even decreases vessel wall dimensions in type II diabetes mellitus patients. Baseline body mass index predicts cardiovascular disease prevention efficacy expressed as decrease in total wall volume. These data emphasize the importance of optimal cardiovascular-prevention, particularly in diabetes patients with a high body mass index.

Source: Diabetes and Vascular Disease Research - February 17, 2015 Category: Endocrinology Authors: Strang, A. C., van Wijk, D. F., Mutsaerts, H. J., Stroes, E. S., Nederveen, A. J., Rotmans, J. I., Rabelink, T. J., Box, F. M. Tags: Original Articles Source Type: research